Becton Dickinson and Co reports results for the quarter ended June 30 - Earnings Summary
Becton Dickinson and Co reports results for the quarter ended June 30 - Earnings Summary
Becton Dickinson and Co BDX.N reported quarterly adjusted earnings of $3.23 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $3.68. The mean expectation of fourteen analysts for the quarter was for earnings of $3.14 per share. Wall Street expected results to range from $3.06 to $3.19 per share.
Revenue fell 9.5% to $4.98 billion from a year ago; analysts expected $4.89 billion.
Becton Dickinson and Co's reported EPS for the quarter was $1.37.
The company reported quarterly net income of $377 million.
Becton Dickinson and Co shares had risen by 12.8% this quarter and gained 11.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 10 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Becton Dickinson and Co is $182.00, about 6.2% above its last closing price of $170.66
This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 3.14 | 3.23 | Beat |
Mar. 31 2026 | 2.77 | 2.90 | Beat |
Dec. 31 2025 | 2.81 | 2.91 | Beat |
Sep. 30 2025 | 3.92 | 3.96 | Beat |
Recent news on Becton Dickinson and
See all newsBrief: Bd Strengthens Leadership In Peripheral Vascular Innovation With Positive Agility Trial Results
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Becton Dickinson rises after pledging $19 billion US investment for tariff relief
Factbox: Global healthcare companies invest billions to boost US presence
Brief: Becton Dickinson To Invest $19 billion In US